Health & Fitness
Health and Fitness
Health and Fitness
Mon, January 12, 2009
Sun, January 11, 2009
Fri, January 9, 2009
Helicos BioSciences to Present at JPMorgan Healthcare Conference on Thursday, January 15, 2009
CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it will present at the JPMorgan Healthcare Conference on Thursday, January 15, 2009. Mr. Ron Lowy, Chief Executive Officer and Mr. Stanley Lapidus, Chairman will present at 10:30 a.m. Pacific time. The conference will take place at the Westin St. Francis Hotel in San Francisco, California. Helicos' presentation will be webcast live and can be accessed through the investor relations section of the Company's website at [ www.helicosbio.com ]. The webcast will be available on the website until February 17, 2009.
About Helicos BioSciences
Helicos BioSciences is a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets. Helicos' proprietary True Single Molecule Sequencing, tSMSTM, technology allows direct measurement of billions of strands of DNA enabling scientists to perform experiments and ask questions never before possible. Helicos is a recipient of the $1,000 genome grant and is committed to providing scientists the tools to unlock the era of genomic medicine. The company's corporate headquarters are located at One Kendall Square, Building 700, Cambridge, MA 02139, and its telephone number is (617) 264-1800.
